Institut National de la Sante et de la Recherche Medicale
Posted: 23 September 2026 - Inserm U1065, France
This position is part of a project funded by INCa PLBIO, aimed at understanding how the oncogene MELK influences melanoma metabolism and immune response. The researcher will employ various techniques including CRISPR/Cas9 and metabolomics to explore these interactions and evaluate potential therapeutic strategies. Candidates should have a strong background in cancer biology and experience with murine models.